baber/WOPTO huggingface dataset:
Patent EP-1781822-A4 (EP)
Inventor: UZGIRIS AREJAS
IPC: C12Q1/68
Filed: 2005-08-19
Abstract: La présente invention concerne une méthode permettant de détecter la présence ou l'absence d'une mutation d'intérêt dans l'acide nucléique d'un agent pathogène, ladite mutation étant adjacente à un polymorphisme de longueur qui définit des quasi-espèces de cet l'agent pathogène.
Patent EP-1789136-A4 (EP)
Title: Interference-free ultrasound imaging during hifu therapy, using software tools
Inventor: VAEZY SHAHRAM
IPC: A61H1/00
Filed: 2005-09-16
Abstract: Disclosed herein is a method for obtaining a composite interference-free ultrasound image when non-imaging ultrasound waves would otherwise interfere with ultrasound imaging. A conventional ultrasound imaging system is used to collect frames of ultrasound image data in the presence of non-imaging ultrasound waves, such as high-intensity focused ultrasound (HIFU). The frames are directed to a processor that analyzes the frames to identify portions of the frame that are interference-free. Interference-free portions of a plurality of different ultrasound image frames are combined to generate a single composite interference-free ultrasound image that is displayed to a user. In this approach, a frequency of the non-imaging ultrasound waves is offset relative to a frequency of the ultrasound imaging waves, such that the interference introduced by the non-imaging ultrasound waves appears in a different portion of the frames.
Patent EP-1841388-A4 (EP)
Title: Frame for an orthopedic brace including offset hinges
Inventor: MASON BRADLEY R
IPC: A61F5/00
Filed: 2005-12-29
Abstract: A frame is provided for an orthopedic brace having a frame assembly and an opposing frame assembly. The frame assembly includes a first longitudinal support and a second longitudinal support rotatably connected by a rotational hinge. The opposing frame assembly includes a first opposing longitudinal support and a second opposing longitudinal support rotatably connected by an opposing rotational hinge. The first longitudinal support has a greater degree of flexibility than the first opposing longitudinal support and/or the second longitudinal support has a greater degree of flexibility than the second opposing longitudinal support to enhance the fit of the frame with the body of a user.
Patent EP-1796881-A4 (EP)
Title: Cutting blade
Inventor: SEE DENNIS E
IPC: B26B9/00
Filed: 2005-08-26
Abstract: A cutting blade includes a metal base and a polymer coating. The cutting blade is adapted to be mounted in a lawn mover or other cutting apparatus.
Patent EP-1799411-A4 (EP)
Title: Impregnation apparatus and method
Inventor: SPENCER COLIN
IPC: B27K3/02
Filed: 2005-09-30
Abstract: Apparel us for impregnating a porous substrate (e.g., wood) with an active agent, including a reservoir for containing a low boiling fluid, a controllable first fluid pathway to permit fluid to flow from the reservoir to a treatment vessel, a fluid junction for introducing the active agent into the first fluid pathway to permit mixing of the active agent with the low boiling fluid to produce an impregnation fluid containing an initial level of active agent and a controllable second fluid pathway to allow fluid to flow from the treatment vessel to the reservoir. The treatment vessel contains the porous substrate while it contacts the impregnation fluid in a liquid state to produce a treated substrate impregnated with the active agent. Also, a method for impregnating a substrate with an active agent, including preparing an impregnation fluid including a low boiling solvent and an active agent, and optionally a co-solvent, contacting the porous substrate with the impregnation fluid in a liquid substrate in an impregnation chamber and removing the impregnation fluid.
Patent EP-1878774-A4 (EP)
Inventor: KANAYA MIHARU
IPC: B41M5/00
Filed: 2006-03-28
Abstract: Cette invention concerne une composition d’encre qui peut produire des images d’une excellente impression brillante sur un support d’impression brillant. La composition d’encre comprend au moins un colorant revêtu d’un polymère insoluble dans l’eau et une émulsion de résine et est caractérisé en ce que le polymère insoluble dans l’eau a une masse moléculaire moyenne en poids de 50 000 à 150 000, l’émulsion de résine comprend une résine d’un composant monomère, qui est du même type que le composant monomère constituant le polymère insoluble dans l’eau, et la résine a une masse moléculaire moyenne en poids de 1,5 à 4 fois plus élevée que la masse moléculaire moyenne en poids du polymère insoluble dans l’eau. En variante, la composition d’encre comprend au moins un colorant revêtu d’un polymère insoluble dans l’eau et des particules de résine et est caractérisée en ce que le colorant revêtu du polymère insoluble dans l’eau est un matériau colorant préparé par un procédé d’émulsion par inversion de phase et les particules de résine sont formées par un polymère préparé par un procédé de polymérisation d’émulsion.
Patent EP-1889683-A4 (EP)
Inventor: UESHIMA MINORU
IPC: B23K35/02
Filed: 2006-05-24
Abstract: 【課題】従来のSn-Zn系鉛フリーは、Znが数10μm程度に大きく晶出し、粗大な晶出物を抑制するこは困難であり、はんだ付け温度を変更させずに接合強度を向上させることは困難であった。はんだに微量の1B属を添加して、強度を改善した合金もあったが、溶融温度が高くなってしまい、Sn-Pbと同じ温度プロファイルではリフローできないという一長一短を有するものであった。
【解決手段】Sn-Zn系鉛フリーソルダペーストのはんだ粉末に、粒子径が５～３００nmで、Ag、Au、Cuから選ばれた１種類以上含んだナノ粒子を含有したエタノール溶液とフラックスとはんだ粉末を混和したソルダペーストを使用することで、はんだ付け時にAg、AuおよびCuとZnの合金を作ることによって、液相中に微細なクラスターを形成させ、溶融後に微細なはんだ組織を得る。
Patent EP-1929711-A4 (EP)
Inventor: FREI RANDALL WAYNE
IPC: H04L12/28
Filed: 2006-07-28
Abstract: L'invention porte sur un protocole de routage de réseau maillé permettant d'optimiser la capacité de transmission de données réseau grâce à une analyse des coûts basée sur une proximité des mailles avec la passerelle ou avec un autre noeud restreint de bande passante. En particulier, le protocole calcule une pluralité de coûts de routage associés à chaque chemin de données, compare les coûts de routage, puis sélectionne le chemin de données associé au coût de routage le plus faible pour la transmission de données. Chaque maille de chaque chemin est pondérée en fonction de sa proximité avec un point d'entrée/sortie du réseau maillé ou avec un autre noeud restreint de bande passante ou avec une autre maille du réseau.
Patent EP-1963367-A4 (EP)
Inventor: ZHOU JOE XIN HUA
IPC: C07K16/00
Filed: 2006-12-06
Abstract: Divers modes de réalisation de la présente invention concernent des systèmes à étapes multiples pour la purification de protéines cibles mettant en oeuvre des étapes de polissage basées sur la chromatographie sur colonne et/ou basées sur la filtration membranaire. Dans un mode de réalisation de la présente invention, un éluat contenant des protéines cibles présentant une concentration élevée de sel résiduel est recueilli à partir d'une première colonne de chromatographie préparée avec une résine de chromatographie d'affinité, chargé sur une seconde colonne de chromatographie préparée avec une résine échangeuse de cations, et élué depuis la seconde colonne de chromatographie d'échange cationique au moyen d'une solution tampon dans lequel une gradient pH variant dans le temps est établi. Dans un autre mode de réalisation de l'invention, un éluat contenant des protéines cibles partiellement purifié est recueilli depuis une colonne de chromatographie et purifié davantage par le passage de l'éluat contenant des protéines cibles à travers un échangeur d'anions tolérant le sel.
Patent EP-1989326-A4 (EP)
Title: Heteroduplex tracking assay
Inventor: PHILPOTT SEAN
IPC: G01N33/53
Filed: 2007-01-17
Abstract: A change in viral tropism occurs in many HIV positive individuals over time and may be indicated by a shift in coreceptor use from CCR5 to CXCR4. The shift in coreceptor use to CXCR4 has been shown to correlate with increased disease progression. In patients undergoing HAART, the predominant populations of virus may be shifted back to CCR5-mediated entry soon after the CXCR4-specific strains have emerged. The present invention relates to a diagnostic method to monitor coreceptor use in the treatment and clinical management of human immunodeficiency virus (HIV) infection. The present invention further relates to a diagnostic method applied to HIV-positive individuals undergoing HAART to monitor the suppression of CCR5- or CXCR4-specific strains. The diagnostic methods may be used to assist in selecting antiretroviral therapy and to improve predictions of disease prognosis over time. The methods of the invention include cell-based methods, including cell fusion assays, and molecular-based methods, including heteroduplex tracking assay, to both quantitatively and qualitatively analyze patient-derived HIV for coreceptor usage.
Patent EP-1995595-A4 (EP)
Title: Method of evaluating skin sensitivity level by using squamous cell carcinoma-related antigen as indication
Inventor: KATAGIRI CHIKA
IPC: G01N33/53
Filed: 2007-03-15
Abstract: The present invention provides a method for evaluating the degree of skin sensitivity by using the expression of squamous cell carcinoma antigen (SCCA) in skin corneocytes as an indicator thereof.
Patent EP-2217843-A4 (EP)
Title: Tube coupling system
Inventor: SANGRO JAN-ERIK
IPC: F16L37/092
Filed: 2007-11-28
Abstract: The present invention relates to a tube coupling system (1) comprising a coupling body (3) for receiving a tube (5), a leakage sealing means (7) between the outer surface of the tube (5) and the inner surface of the coupling body (3), a gripping means (9) for gripping the outer surface of the tube (5) received in the coupling body (3), and a tube support body (19) onto which the tube (5) fits, characterised in that said tube support body (19) comprises a feedback element (20) that provides an audible feedback signal when the tube (5) is sufficiently inserted onto the tube support body (19).
Patent EP-2200716-A4 (EP)
Title: Treadmill with automatic speed control, control module of the same and control method of the same
Inventor: PARK JAE-SANG
IPC: A63B22/02
Filed: 2008-01-31
Abstract: A treadmill includes a body having a belt for supporting an exerciser, an exerciser detecting portion installed in a predetermined area of the body to detect movement of the exerciser, a driving motor coupled to the body to drive the belt, a control portion for generating a first control signal for adjusting a rotation speed of the driving motor based on a signal received from the exerciser detecting portion, a motor driving portion for adjusting the rotation speed of the driving motor according to the first control signal received from the control portion, and an electrical braking portion for reducing the rotation speed of the driving motor. The treadmill quickly follows acceleration or deceleration of an exerciser; provides an experience as if the exerciser is exercising on the ground, thereby improve an exerciser's exercising experience; accepts various exercising patterns of an exerciser; resolves a problem in that a motor driving portion is tripped due to a load caused by quick deceleration; and preprocesses measured values of an exerciser's position to resolve a problem in that a speed of a belt cannot be controlled due to measurement errors contained in measured values.
Patent EP-2328259-A4 (EP)
Title: System and method for power management in a photovoltaic installation
Inventor: GONZALEZ SENOSIAIN ROBERTO
IPC: H02J3/48
Filed: 2008-08-12
Abstract: The subject matter of the invention is the provision of a power-management system and method for photovoltaic installations connecting to the grid, which incorporates monitoring active and/or reactive power, account being taken at all times of grid requirements, in order to allow temporary demand arising in the grid to be addressed, thereby contributing to regulation of the grid and to the stability and quality thereof.
Patent EP-2289995-A4 (EP)
Title: Polyvinyl chloride resin composition and method for producing the same
Inventor: KATO MASAKI
IPC: C08L27/06
Filed: 2009-06-15
Abstract: The present invention relates to a polyvinyl chloride resin composition comprising: from 0.005 to 5 parts by weight of a vinyl alcohol-based polymer containing from 0.5 to 18 mol% of an ethylene unit and having a degree of saponification of a vinyl acetate unit of from 30 to 99.9 mol%; and from 0.01 to 5 parts by weight of a zinc compound, based on 100 parts by weight of a polyvinyl chloride resin.
Patent EP-2413964-A4 (EP)
Title: Vaccine compositions and methods of use thereof
Inventor: DAFTARIAN PIROUZ MOHAMMAD
IPC: A61K39/38
Filed: 2010-04-01
Abstract: Nanoparticle-based vaccines, compositions, kits and methods are used for the effective delivery of one or more antigens in vivo for vaccination and antibody (e.g., monoclonal antibody) production, and for the effective delivery of peptides, proteins, siRNA, RNA or DNA to PAPCs or MHC class II positive cells (e.g. tumor cells). Antigens may be, for example, DNA that results in expression of the gene of interest and induction of a robust and specific immune response to the expressed protein in a subject (e.g., mammal). Antigens may also be immunogenic peptides or polypeptides that are processed and presented. In one embodiment, a nanoparticle -based method to deliver antigens in vivo as described herein includes injection of a vaccine composed of a DNA encoding at least one antigen, or at least one antigenic peptide or polypeptide conjugated to a charged dendrimer (e.g., PADRE-derivatized dendrimer) that is also conjugated to a T helper epitope (e.g., PADRE). Negatively-charged plasmids bind naturally to a positively-charged PADRE-dendrimer, while peptide or polypeptide antigens can be chemically linked to the PADRE-dendrimer if they are not negatively-charged. Alternatively, negatively-charged dendrimers may be used. The compositions, kits, vaccines and methods described herein have both prophylactic and treatment applications, i.e., can be used as a prophylactic to prevent onset of a disease or condition in a subject, as well as to treat a subject having a disease or condition. A vaccine as described herein can be used to mount an immune response against any infectious pathogen or cancer.
Patent EP-2579895-A4 (EP)
Title: Anti-vegf antibodies and uses thereof
Inventor: CROY LESLIE A
IPC: C07K16/22
Filed: 2011-06-14
Abstract: Provided are monoclonal antibodies and antigen binding fragments thereof that specifically bind vascular endothelial growth factor (VEGF). The anti-VEGF monoclonal antibodies block VEGF binding to its receptors (e.g., VEGFR1 and/or VEGFR2) and prevent phosphorylation of VEGFR2 by VEGF. Also provided are methods of using the monoclonal anti-VEGF antibodies for treatment of disease, including cancer.
Patent EP-0119196-A4 (EP)
Inventor: CHANG YUN FENG
IPC: C08J9/02
Filed: 1982-09-20
Abstract: Composition d'uréthane dilatable utilisée comme mastic et caractérisée en ce qu'elle comprend un premier composant contenant un mélange d'un élastomère réactif liquide hydroxy fonctionnel et de sels métalliques de sulfonates organiques, ainsi qu'un deuxième composant contenant du polyisocyanate. La composition peut aussi contenir des pigments et/ou des charges. Le mastic de mousse présente d'excellentes propriétés de flexibilité, de résistance à l'abrasion et aux chocs, et d'isolation phonique, et adhère avantageusement aux surfaces graisseuses.
Patent EP-0248037-A4 (EP)
Title: Blood serum test strip.
Inventor: KENNEDY PAUL R
IPC: C12Q1/00
Filed: 1986-10-16
Abstract: Single or multiple blood plasma component concentrations are measured by a disposable stick having one or more blood plasma component reactive areas covered by a semipermeable membrane which is permeable by blood plasma or serum components and impermeable by blood cellular and particulate matter. A second overlay may be superposed with the semipermeable membrane over the reactive areas to receive a blood sample and meter and distribute that sample uniformly to the semipermeable membrane which in turn passes the plasma components uniformly to the reactive areas. The overlays are subsequently separable from the reactive area to remove the cellular components and particulate matter and expose the reactive areas for inspection by, for example, color comparison to standardized charts.
Patent EP-0346465-A4 (EP)
Title: 1-carboxy-1-vyniloxyiminoaminothiazole cephalosporing derivatives and process for their preparation.
Inventor: NAKAGAWA SUSUMU
IPC: A61K31/545
Filed: 1987-04-14
Abstract: PCT No. PCT/JP87/00236 Sec. 371 Date Oct. 13, 1988 Sec. 102(e) Date Oct. 13, 1988 PCT Filed Apr. 14, 1987 PCT Pub. No. WO87/06232 PCT Pub. Date Oct. 22, 1987.The present invention relates to a compound having the formula:    <IMAGE>  (I)  wherein R is a hydrogen atom, a carboxyl-protecting group or a negative charge and Q is a hydrogen atom, a halogen atom, a hydroxyl group, an acetoxy group, a carbamoyl group, an azide group, a substituted or unsubstituted quarternary ammonio group or a substituted or unsubstituted heterocyclic thio group having at least one hetero atom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, or a non-toxic salt or physiologically hydrolyzable non-toxic ester thereof; a process for producing it; and an antibacterial agent comprising it as an active ingredient. Further, the present invention also relates to a compound having the formula:    <IMAGE> (III) wherein R3 is a hydrogen atom or an amino-protecting group, and each of R4 and R5 which may be the same or different is a hydrogen atom or a carboxyl-protecting group, or a salt thereof; and a process for producing it.
Patent EP-0331756-A4 (EP)
Title: Agents for prophylaxis and treatment of thrombopenia
IPC: C07K9/00
Filed: 1988-09-02
Abstract: Agents for prophylaxis and treatment of thrombopenia, which contain as an effective ingredient a muramyldipeptide derivative represented by general formula (I) (wherein X represents a residue of an amino acid selected from among L-alanine, L-serine and L-valine, Y represents (II), R1 represents a carboxyl group, n represents an integer of 1 to 6, A represents a saturated, optionally branched aliphatic hydrocarbyl residue containing 7 to 29 carbon atoms, and Acyl represents an acyl group containing 2 to 6 carbon atoms). The agents show an excellent effect for prophylaxis and treatment of thrombopenia.
Patent EP-0422068-A4 (EP)
Title: Pharmacological treatment of ocular development
IPC: A61K31/445
Filed: 1989-06-01
Abstract: A method of controlling the abnormal postnatal growth of the eye of a maturing animal which comprises the ocular administration of therapeutically effective amounts of a dopamine antagonist.
Patent EP-0428568-A4 (EP)
Title: Multiaxially oriented thermotropic polymer films and method of preparation
IPC: B29C48/10
Filed: 1989-06-13
Abstract: This invention relates in general to the formation of multiaxially (e.g., biaxially) oriented films from high molecular weight liquid crystalline thermotropic polymers (homopolymers, copolymers, and the like), wherein due to the processing conditions employed, the films have a controlled molecular orientation. The novel multiaxially oriented films of the present invention are preferably prepared from two commercially available thermotropic polymers, Datrco Manufacturing, Incorporated's XYDAR TM  LCP and Hoechst Celanese's VECTRA TM  LCP.
Patent EP-0436639-A4 (EP)
Title: Multifunctional photolithographic compositions
IPC: G03F7/085
Filed: 1989-09-25
Abstract: A photolithographic composition comprised of poly(vinylpyridine), a non-photosensitive light attenuating material and a solvent having a molecular weight from about 70 to 120 and a flashpoint from about 28 degrees C to about 45 degrees C, the method of making that composition, its use in a photographable article and its use in a method for dry-etching a photolithographic image into a micro-electronic substrate without the need for an oxygen-etch barrier layer.
Patent EP-0429672-A4 (EP)
IPC: C08G2/08
Filed: 1990-06-18
Abstract: Un copolymère d'acétal avec un indice de viscosité compris entre 0,1 et 10dk/g et une excellente isotropie est formé d'une unité de polyacétal et d'une unité de polymère fragmenté à réticulation croisée. On produit ce copolymère en faisant réagir un polyacétal avec un polymère fragmenté à réticulation croisée autre que du polyacétal, ayant des particules d'un diamètre moyen compris entre 0,01 et 10 ν et un groupe fonctionnel sélectionné parmi des groupes hydroxyles, carboxyles, amines, amides, alcoxyles, anhydrides acides et époxydes, afin de les relier mutuellement au moyen de ces groupes fonctionnels. On produit un autre copolymère d'acétal avec un indice de viscosité compris entre 0,1 et 10 dl/g, formé d'une unité de polyacétal et d'une autre unité polymère, en homopolymérisant ou en copolymérisant du formaldéhyde ou du trioxane avec un éther cyclique en présence d'un polymère autre que le polyacétal, ce polymère ayant un diamètre de dispersion moyen compris entre 0,01 et 2.000 ν et des groupes fonctionnels sélectionnés parmi des groupes hydroxyles, carboxyles, amines, amides, alcoxyles, anhydrides acides et époxydes, qui servent à relier le polyacétal ainsi produit avec le polymère autre que le polyacétal.
Patent EP-0447517-A4 (EP)
IPC: F16F9/52
Filed: 1990-09-07
Abstract: Un ressort (10) comprend une première dérivation (26a, 28a, 30, 32) dotée d'une vanne unidirectionnelle (30) permettant à du fluide de contourner le piston (26) lorsque ce dernier se déplace vers l'extérieur, une seconde dérivation (32) dotée d'une vanne (30) à ressort permettant à du fluide de contourner ledit piston (26) lorsque ce dernier (26) est poussé vers l'intérieur avec une force dépassant les forces combinées du ressort à gaz et de la vanne à ressort, ainsi qu'une troisième dérivation (40, 42, 50) dotée d'une vanne (44) thermosensible, permettant à du fluide de contourner ledit piston (26) lorsque la tige (18) est rentrée, mais uniquement lorsque la température du gaz dépasse un niveau sélectionné.
Patent EP-0502127-A4 (EP)
Title: Catalytic hydrogen storage electrode materials for use in electrochemical cells incorporating the materials
Inventor: FETCENKO MICHAEL A
IPC: C01B6/00
Filed: 1990-11-20
Abstract: Disclosed is a reversible, electrochemical cell (10) having a high electrochemical activity, hydrogen storage negative electrode (12). The negative electrode is formed of a reversible, multicomponent, multiphase, electrochemical hydrogen storage alloy. The hydrogen storage alloy is capable of electrochemically charging and discharging hydrogen in alkaline aqueous media. In one preferred exemplification the hydrogen storage alloy is a member of the family of hydrogen storage alloys, derived from the V-Ti-Zr-Ni-Cr and V-Ti-Zr-Ni-Cr alloys in which the V, Ti, Zr, Ni and Cr are partially replaced by one or more modifiers, and the alloy has the composition: (Vy'-yNiyTix'-xZrxCrz)aM'bM''cM'''dM''''e, where x' is between 1.8 and 2.2, x is between 0 and 1.5, y' is between 3.6 and 4.4, y is between 0.6 and 3.5, z is between 0.00 and 1.44, a designates that the V-Ni-Ti-Zr-Cr component, as a group is from 70 to 100 atomic percent of the alloy, b, c, d, e, ..., are the coefficients on the modifiers, and M', M'', and M<i> are modifiers which may be individually or collectively up to 30 atomic percent of the total alloy. The modifiers, and M', M'', M<iii>, and M<iv> are modifiers which may be individually or collectively up to 30 atomic percent of the total alloy. The modifiers, M', M'', M<iii>, and M<iv> are chosen from Al, Mn, Mo, Cu, W, Fe, Co, Si, Sn, Zn and combinations thereof.